Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.
about
Reinventing diagnostics for personalized therapy in oncologyDiscovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/DoxAssociation of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data ApproachUtilizing the molecular gateway: the path to personalized cancer management.Data mining in genomicsIdentification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.A stromal gene signature associated with inflammatory breast cancer.TAF6delta controls apoptosis and gene expression in the absence of p53.Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.TAF6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53.The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathwaysUtility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy.EMT is the dominant program in human colon cancer.A bayesian analysis strategy for cross-study translation of gene expression biomarkers.High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.Alternative splicing of TAF6: downstream transcriptome impacts and upstream RNA splice control elements.Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity.RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.In silico models of cancerHyperthermia for locally advanced breast cancer.AN INTEGRATIVE ANALYSIS OF CANCER GENE EXPRESSION STUDIES USING BAYESIAN LATENT FACTOR MODELING.A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics.High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response.Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compGenomic and expression analysis of microdissected inflammatory breast cancer.Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice.Limitations of pharmacogenomic predictor discovery in Phase II clinical trials.Clinical states model for biomarkers in bladder cancerGenomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.Genomic predictors of outcome and treatment response in breast cancer.Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
P2860
Q28391395-40AE8285-7FBE-4BC2-83C6-27C80644D434Q28477021-8C1A906B-B098-455D-BEAC-A8E40C69AC2EQ30000323-984A7D83-C23C-4134-96F4-5291D29968CDQ30371443-B2CFBE3C-F9DB-46D2-8F75-82D01E8F0F6CQ30440132-A0292B23-A351-48FC-9B93-7F857742ED22Q30477571-F815C1E3-84BE-437D-A37D-CF449ED30709Q30838525-B11A87EA-3F7C-4118-846D-53F3FBA151CFQ33351996-F6C2D458-43CF-4178-B9D3-CDB5C4B9D805Q33371410-90D23715-AA5E-4BD0-B4A3-2524245451B5Q33446416-443B15D0-3B40-489B-BF44-E6F12AF889EFQ33526062-699086A5-1665-46EC-B3F6-6CC22E22AC6CQ33597010-3B3AC6FC-331B-46EB-BC0A-DF923FD58768Q33790254-79986B49-2972-4D85-9E70-F5F9C99984C6Q33798739-31B4055F-4A3D-477A-9AB5-EA2D9FB3EADEQ33817283-2CF99EC7-3878-4AC5-BB80-45DFC400D498Q33826097-C53D6EBD-2CE9-48F6-907B-AA24C4A82164Q33905777-5AB4D0E6-004D-4D0D-9294-0327BE4EDAD1Q34005100-7FD74D52-4059-4593-9C86-CBD21D086706Q34042708-1B6F6D0E-9CD6-48B1-9E08-84A2DB68222AQ34048144-8E76C7A1-4388-40A3-A4F5-D54479906344Q34137584-FC3834E3-2ACE-484F-98C8-A0390212B9A7Q34171535-ADCD6179-8C2E-487C-9B75-63AB51835070Q34196222-C4E5B3BC-FCD8-4B1B-83E0-683E8D964A58Q34207279-B45C68B9-1BE1-48E2-B440-D7512A2F79F7Q34473061-896A1204-9ED4-495B-A0B0-0A6040A721F8Q35605840-4858BFB9-7F30-4479-A5A5-500DE38DA6E9Q35775570-589FFB2A-E473-4D74-9630-B7A59D7495ECQ35794390-3A8602B6-AE27-4CAA-814F-D648C1D137E5Q35922605-2315821A-BDDA-4BCC-9BF5-49BF60275620Q36489338-39BA956C-8854-4B91-A9E8-3C5185EDCFBBQ36851342-1DDB19FA-16D5-4FA5-A1D1-6D2597FC84D7Q36916724-03B331A5-754F-422D-8B32-65CD07A2F678Q36977583-F098835F-36F9-45DF-B0C2-83373BCCC3F1Q36989854-0A22CDB1-C450-4AC7-882B-0E706A7410B1Q36995765-4A8D47FD-8C7F-4109-AC06-50FE6930EFABQ37114252-EC78B3FB-265A-4748-AF80-5AFC26FFA791Q37138140-12FB053E-D9EA-4917-8AEC-9488B090A26DQ37518882-FCBFE67F-C17F-4AE1-B859-433DBAD1A1A0Q37523889-C5746672-DD69-48B7-812D-94CAE4488972Q37528475-B6305729-A27C-4E68-ADCE-992015165F57
P2860
Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@ast
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@en
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@nl
type
label
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@ast
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@en
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@nl
prefLabel
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@ast
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@en
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@nl
P2093
P1476
Gene expression profiles of mu ...... e to neoadjuvant chemotherapy.
@en
P2093
Andrea Bild
Christopher Hans
Ellen L Jones
Eric Rosen
Holly K Dressman
Jeffrey Marks
John A Olson
Joseph R Nevins
Kimberly Blackwell
Mark W Dewhirst
P304
P356
10.1158/1078-0432.CCR-05-1447
P407
P433
P577
2006-02-01T00:00:00Z